Hydroxamate inhibitors of interleukin-1.beta. converting enzyme
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 6, 1999
Grant Date -
N/A
app pub date -
Oct 2, 1997
filing date -
Oct 11, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula II ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully